Real-time enrollment status for this prostate cancer (adenocarcinoma) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:45 PM UTC
| NCT Number | NCT06592924 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer (Adenocarcinoma) |
| Phase | PHASE3 |
| Target Enrollment | 830 participants |
| Active Locations | 374 sites in the US |
| Sponsor | Canadian Cancer Trials Group |
| Last Updated on CT.gov | July 14, 2026 (Jul 14, 2026) |
As of October 12, 2026: Clinical trial NCT06592924 is currently recruiting participants. This phase3 study for prostate cancer (adenocarcinoma) is actively seeking new participants at 374 locations across the United States. The study is sponsored by Canadian Cancer Trials Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06592924 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 374 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06592924 was last updated Jul 14, 2026 (July 14, 2026). HelloStudys verifies this status automatically.